Day 1: 2nd Biennial Pediatric Oncology Integrative Diagnostics and Targeted Therapies Symposium

Wednesday, September 9, 2026, 11:15 AM - 5:15 PM, Nationwide Children's Hospital Conference Center, Columbus, OH


AMA PRA Category 1 Credits™ (4.50 hours), ACPE Contact Hour(s) (4.50 hours), ANCC Contact Hour(s) (4.50 hours), APA Credit(s) (4.50 hours), ASWB ACE Credit(s) (4.50 hours), Non-Physician Attendance (4.50 hours)

Our second biennial Pediatric Oncology Integrative Diagnostics and Targeted Therapies Symposium, sponsored by the Nationwide Children’s Hospital Division of Hematology, Oncology, and Blood & Marrow Transplant, in collaboration with the Institute for Genomic Medicine, will provide a comprehensive overview across three days of current and developing diagnostic and therapeutic approaches. These sessions, anchored by four plenary speakers, will empower pediatric oncology teams to integrate these new tools at each stage of care of children with cancer.

Companies who are interested in having an informational table at the conference should register under the "Exhibitors" tab.

Workshops 

**Please note: the workshops will be limited for the virtual attendees **

We are excited to offer this year dedicated interactive workshops on a host of topics related to the use of integrative diagnostics and targeted therapies in children, adolescents and young adults with cancers. These will be small group sessions with opportunities for case review and Q&A. 

In person attendees, you will be able to select up to 3 topics which you would like to attend from the following:

• Nursing Considerations of Targeted Therapies: This session will be led by nursing representation from Nationwide Children's and discuss the management considerations of patients receiving different classes of targeted therapies, both in the inpatient and outpatient setting. 

• Pharmacy Considerations of Targeted Therapies: This session will be led by pharmacists and pharmacologists from Nationwide Children's and discuss the management considerations of patients receiving different classes of targeted therapies, both in the inpatient and outpatient setting. 

• Psychosocial Considerations of Targeted Therapies: This session will review specific case vignettes that reflect the patient-facing implications of targeted therapies, including barriers to care and overall care considerations. 

• Regulatory Perspectives on Targeted Therapies: We will host members experienced in the regulatory process of the development and approval of targeted therapies, addressing key topics and barriers to evaluation of novel and existing agents and innovative solutions. 

• Working with Pharma: This session will elucidate the working structure of pharma and how to optimally partner with them for best clinical and research practice. 

• Partnering with Advocacy and Philanthropy: This session will facilitate direct collaboration with advocacy, optimizing how to best work toward shared goals and understand the mission of patients, families, and advocacy organizations.

• Mentors and Mentees: This session will discuss how to develop new mentorships and how to optimize interactions for mentors and mentees at different points in their career.

In support of improving patient care, Nationwide Children's Hospital is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the American Nurses Credentialing Center (ANCC),  and the Accreditation Council for Pharmacy Education (ACPE), to provide continuing medical education for the healthcare team.

Cancellation Policy

Cancellations received in writing no less than 20 days before the course will be refunded, less a 20% administrative fee. No refunds will be made on cancellations received after that date. Please send cancellation requests to [email protected].

Nationwide Children's Hospital reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 
Nationwide Children's Hospital is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

The Nationwide Children's Hospital® adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Nationwide Children's Hospital adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Wednesday, September 9, 2026